RESUMO
BACKGROUND: In racehorses, serum gamma-glutamyltransferase (GGT) activity is positively correlated with cumulative days in training and, when ≥100 IU/L, has been associated with poor performance. The prevalence of increased GGT activity in North American Thoroughbreds and its aetiopathogenesis are unknown. Four emerging viruses, pegivirus E (PgV E; equine pegivirus), hepacivirus A (HcV A; equine hepacivirus), pegivirus D (PgV D; Theiler's disease virus), and equine parvovirus-hepatitis (EqPV-H) have been identified in horses with clinical and subclinical hepatopathy. Available prevalence data indicate these viruses may commonly infect racehorses and contribute to increased liver enzyme activity in this population. OBJECTIVES: To investigate the association between viral infection and increased liver enzyme activity in racing Thoroughbreds. STUDY DESIGN: Cross-sectional study. METHODS: Prerace blood samples were collected from 802 Thoroughbreds and tested for GGT and sorbitol dehydrogenase (SDH) activity, and the presence of PgV E, HcV A, PgV D and EqPV-H nucleic acid. RESULTS: Increased SDH and/or GGT were detected in 56.2% of the 802 serum samples. The infection prevalence and relative risk (RR) of having concurrently increased liver enzyme activity were: PgV E = 18.2% (RR = 0.820, 95% CI = 0.662-0.978, P = 0.03), HcV A = 2.5% (RR = 1.132, 95% CI = 0.719-1.466, P = 0.6), PgV D = 0.5% (RR = 0.875, 95% CI = 0.165-1.598, P>0.9), EqPV-H = 2.9% (RR = 0.916, 95% CI = 0.564-1.266, P = 0.7). MAIN LIMITATIONS: Longitudinal samples were not tested. CONCLUSIONS: While viral infection was common among Thoroughbreds in this study, infection did not explain the high prevalence of increased liver enzyme activity. In fact, PgV E infection was associated with a reduced risk of having increased liver enzyme activity, indicating PgV E is unlikely to be a cause of hepatitis in horses. Importantly, like GGT, increased SDH activity was highly prevalent in this study, and provides additional evidence that hepatocellular injury was occurring in these horses.
Assuntos
Infecções por Flaviviridae/veterinária , Doenças dos Cavalos/virologia , L-Iditol 2-Desidrogenase/metabolismo , Infecções por Parvoviridae/veterinária , gama-Glutamiltransferase/metabolismo , Animais , Biomarcadores , Doenças Transmissíveis Emergentes/veterinária , Doenças Transmissíveis Emergentes/virologia , Flaviviridae/classificação , Infecções por Flaviviridae/sangue , Infecções por Flaviviridae/virologia , Regulação Enzimológica da Expressão Gênica , Cavalos , L-Iditol 2-Desidrogenase/genética , Fígado/enzimologia , Infecções por Parvoviridae/virologia , Parvovirinae , gama-Glutamiltransferase/genéticaRESUMO
Equine piroplasmosis is caused by one of 2 erythrocytic parasites Babesia caballi or Theileria equi. Although the genus of the latter remains controversial, the most recent designation, Theileria, is utilized in this review. Shared pathogenesis includes tick-borne transmission and erythrolysis leading to anemia as the primary clinical outcome. Although both parasites are able to persist indefinitely in their equid hosts, thus far, only B. caballi transmits across tick generations. Pathogenesis further diverges after transmission to equids in that B. caballi immediately infects erythrocytes, whereas T.equi infects peripheral blood mononuclear cells. The recent re-emergence of T.equi in the United States has increased awareness of these tick-borne pathogens, especially in terms of diagnosis and control. This review focuses in part on factors leading to the re-emergence of infection and disease of these globally important pathogens.
Assuntos
Babesia/crescimento & desenvolvimento , Babesiose/veterinária , Doenças dos Cavalos/parasitologia , Theileria/crescimento & desenvolvimento , Theileriose/parasitologia , Carrapatos/parasitologia , Animais , Babesiose/sangue , Babesiose/epidemiologia , Babesiose/parasitologia , Babesiose/transmissão , Doenças dos Cavalos/sangue , Doenças dos Cavalos/epidemiologia , Doenças dos Cavalos/transmissão , Cavalos , Prevalência , Theileriose/sangue , Theileriose/epidemiologia , Theileriose/transmissão , Estados Unidos/epidemiologiaRESUMO
The control of EHV-1 infection by cytotoxic T-cell responses (CTL) via a reduction in cell associated viremia remains an important goal in horses. Unfortunately, current vaccines are inefficient at inducing these responses. We have identified the immediate early (IE) gene of EHV-1 as a potent stimulator of virus-specific CTL responses in ponies expressing a specific MHC class I serological haplotype (A3/B2). This study was designed to determine if vaccination of A3/B2 MHC I positive ponies with the IE gene could induce protection and immune responses associated with cell mediated immunity. Ponies expressing the MHC-I A3/B2 haplotype (A3/B2 vaccinates) and ponies with a different MHC I haplotype (either non-A3 vaccinates or A3-non-B2 vaccinates) were vaccinated with a recombinant modified vaccinia Ankara (rMVA) vector expressing the IE gene on 3 occasions and vaccinates and unvaccinated controls were challenge infected 8 weeks after the last vaccination. Interferon gamma (IFN-gamma) mRNA and antibody titers were determined throughout the study and clinical signs, nasal virus shedding and viremia were determined following challenge infection. Vaccination of A3/B2 vaccinates conferred significant clinical protection and a significant reduction in EHV-1 viremia. IFN-gamma mRNA increased significantly following vaccination in the A3/B2 vaccinates. Antibody titers remained low until after challenge infection, indicating that no accidental field acquired or recrudescent EHV-1 infection had occurred. In summary, this is an important study showing that vaccination of ponies with the EHV-1 IE protein provides not only reduction in clinical disease but also reduction of cell associated viremia, which is a prerequisite for the prevention of abortion and neurological disease.
Assuntos
Infecções por Herpesviridae/veterinária , Herpesvirus Equídeo 1/imunologia , Vacinas contra Herpesvirus/uso terapêutico , Doenças dos Cavalos/prevenção & controle , Animais , Anticorpos Neutralizantes/sangue , Feminino , Genes Precoces/genética , Genes Precoces/imunologia , Genótipo , Infecções por Herpesviridae/imunologia , Infecções por Herpesviridae/prevenção & controle , Herpesvirus Equídeo 1/genética , Vacinas contra Herpesvirus/genética , Vacinas contra Herpesvirus/imunologia , Doenças dos Cavalos/imunologia , Cavalos/imunologia , Cavalos/virologia , Interferon gama/sangue , Masculino , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologia , Vacinas Sintéticas/uso terapêutico , Vacínia , Viremia/imunologia , Viremia/veterináriaRESUMO
We developed a replication-defective reporter virus pseudotyped with the envelope glycoprotein of equine infectious anemia virus (EIAV). The in vitro host range and neutralization phenotype of EIAV Env-pseudotyped virus were similar to those of replication-competent virus. An EIAV Env pseudovirus will improve antigenic characterization of viral variants and evaluation of lentivirus vaccines.
Assuntos
Anemia Infecciosa Equina/imunologia , Engenharia Genética , Vírus da Anemia Infecciosa Equina/imunologia , Proteínas do Envelope Viral/imunologia , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/imunologia , Antígenos Virais/imunologia , Linhagem Celular , Anemia Infecciosa Equina/virologia , Cavalos , Vírus da Anemia Infecciosa Equina/metabolismo , Testes de Neutralização , Proteínas do Envelope Viral/metabolismoRESUMO
Improving the ability of DNA-based vaccines to induce potent Type1/Th1 responses against intracellular pathogens in large outbred species is essential. Rhodoccocus equi and equine infectious anemia virus (EIAV) are two naturally occurring equine pathogens that also serve as important large animal models of neonatal immunity and lentiviral immune control. Neonates present a unique challenge for immunization due to their diminished immunologic capabilities and apparent Th2 bias. In an effort to augment R. equi- and EIAV-specific Th1 responses induced by DNA vaccination, we hypothesized that a dual promoter plasmid encoding recombinant equine IL-12 (rEqIL-12) would function as a molecular adjuvant. In adult horses, DNA vaccines induced R. equi- and EIAV-specific antibody and lymphoproliferative responses, and EIAV-specific CTL and tetramer-positive CD8+ T lymphocytes. These responses were not enhanced by the rEqIL-12 plasmid. In neonatal foals, DNA immunization induced EIAV-specific antibody and lymphoproliferative responses, but not CTL. The R. equi vapA vaccine was poorly immunogenic in foals even when co-administered with the IL-12 plasmid. It was concluded that DNA immunization was capable of inducing Th1 responses in horses; dose and route were significant variables, but rEqIL-12 was not an effective molecular adjuvant. Additional work is needed to optimize DNA vaccine-induced Th1 responses in horses, especially in neonates.
Assuntos
Vírus da Anemia Infecciosa Equina/imunologia , Interleucina-12/imunologia , Rhodococcus equi/imunologia , Vacinas de DNA/imunologia , Animais , Animais Recém-Nascidos , Anticorpos Antivirais/sangue , Linfócitos T CD8-Positivos/imunologia , Vias de Administração de Medicamentos , Ensaio de Imunoadsorção Enzimática , Cavalos , Esquemas de Imunização , Interleucina-12/genética , Camundongos , Células NIH 3T3 , Proteínas Recombinantes/imunologia , Linfócitos T Citotóxicos/imunologia , Células Th1/imunologiaRESUMO
Acute infection with equine infectious anemia virus (EIAV), a lentivirus of horses, results in a persistent high-level viremia in Arabian foals affected with severe combined immunodeficiency (SCID). This observation argues against the idea that the transient nature of acute lentiviral viremia is solely a function of viral population dynamics. To extend these studies, EIAV-specific immune reconstitution was attempted prior to EIAV challenge in two SCID foals, using adoptively transferred virus-stimulated lymphocytes derived from persistently EIAV-infected half sibling donors. Following transfer, lymphocyte engraftment occurred in one foal, and EIAV-specific cytotoxic T lymphocytes as well as neutralizing antibody activity developed. Following a brief period of plasma viremia in this foal, EIAV replication was controlled and plasma virus could not be detected by RT-PCR or culture. These results provide further direct evidence that a specific immune response is required for termination of plasma viremia in acute lentiviral infections.
Assuntos
Doenças dos Cavalos/imunologia , Vírus da Anemia Infecciosa Equina/fisiologia , Imunodeficiência Combinada Severa/veterinária , Replicação Viral , Transferência Adotiva , Animais , Doenças dos Cavalos/virologia , Cavalos , Vírus da Anemia Infecciosa Equina/imunologia , Imunodeficiência Combinada Severa/imunologia , Imunodeficiência Combinada Severa/virologia , Linfócitos T Citotóxicos/imunologiaRESUMO
OBJECTIVE: To validate use of high-performance liquid chromatography (HPLC) in determining imipramine concentrations in equine serum and to determine pharmacokinetics of imipramine in narcoleptic horses. ANIMALS: 5 horses with adult-onset narcolepsy. PROCEDURE: Blood samples were collected before (time 0) and 3, 5, 10, 15, 20, 30, and 45 minutes and 1, 2, 3, 4, 6, 8, 12, and 24 hours after IV administration of imipramine hydrochloride (2 or 4 mg/kg of body weight). Serum was analyzed, using HPLC, to determine imipramine concentration. The serum concentration-versus-time curve for each horse was analyzed separately to estimate pharmacokinetic values. RESULTS: Adverse effects (muscle fasciculations, tachycardia, hyperresponsiveness to sound, and hemolysis) were detected in most horses when serum imipramine concentrations were high, and these effects were most severe in horses receiving 4 mg of imipramine/kg. Residual adverse effects were not apparent. Value (mean +/- SD) for area under the curve was 3.9 +/- 0.7 h X microg/ml, whereas volume of distribution was 584 +/- 161.7 ml/kg, total body clearance was 522 +/- 102 ml/kg/h, and mean residence time was 1.8 +/- 0.6 hours. One horse had signs of narcolepsy 6 and 12 hours after imipramine administration; corrresponding serum imipramine concentrations were less than the therapeutic range. CONCLUSIONS AND CLINICAL RELEVANCE: Potentially serious adverse effects may be seen in horses administered doses of imipramine that exceed a dosage of 2 mg/kg. Total body clearance of imipramine in horses is slower than that in humans; thus, the interval between subsequent doses should be longer in horses.
Assuntos
Antidepressivos Tricíclicos/farmacocinética , Doenças dos Cavalos/metabolismo , Cavalos/metabolismo , Imipramina/farmacocinética , Narcolepsia/veterinária , Animais , Antidepressivos Tricíclicos/efeitos adversos , Antidepressivos Tricíclicos/sangue , Área Sob a Curva , Cromatografia Líquida de Alta Pressão/veterinária , Feminino , Doenças dos Cavalos/sangue , Doenças dos Cavalos/tratamento farmacológico , Imipramina/efeitos adversos , Imipramina/sangue , Masculino , Narcolepsia/sangue , Narcolepsia/tratamento farmacológico , Narcolepsia/metabolismoRESUMO
Hepatic abscesses were diagnosed in 3 adult horses. Two were < 4 years old and had evidence of concurrent immune-mediated conditions, including aseptic arthritis, immune-mediated thrombocytopenia, and immune-mediated anemia. Predisposing factors for hepatic abscess formation in these horses included prior abdominal surgery, proximal duodenitis/jejunitis, inflammatory bowel disease, and a penetrating foreign body in the large colon. Serum hepatic enzyme activities were within or slightly greater then reference limits in all 3 horses. The most pronounced and consistent abnormalities on CBC and serum biochemical analyses were hyperproteinemia, hyperglobulinemia, and a decreased albumin-to-globulin concentration ratio. Hepatic ultrasonography identified hepatic abscesses in all 3 horses. A variety of bacteria were isolated from these abscesses, including Staphylococus aureus and Bacteroides fragilis. One horse developed septic tibiotarsal arthritis, presumably as a result of intermittent bacteremia. Despite aggressive medical treatment, all horses were euthanatized because of a worsening condition and poor prognosis.
Assuntos
Doenças dos Cavalos/patologia , Abscesso Hepático/veterinária , Animais , Antibacterianos/uso terapêutico , Feminino , Doenças dos Cavalos/tratamento farmacológico , Doenças dos Cavalos/cirurgia , Cavalos , Abscesso Hepático/tratamento farmacológico , Abscesso Hepático/cirurgia , MasculinoRESUMO
Glycoprotein adhesion receptors such as selectins contribute to tissue injury in stroke. Ischemic neurons strongly expressed C1q, which may target them for complement-mediated attack or C1qRp-mediated clearance. A hybrid molecule was used to simultaneously inhibit both complement activation and selectin-mediated adhesion. The extracellular domain of soluble complement receptor-1 (sCR1) was sialyl Lewis x glycosylated (sCR1sLex) to inhibit complement activation and endothelial-platelet-leukocyte interactions. sCR1 and sCR1sLex colocalized to ischemic cerebral microvessels and C1q-expressing neurons, inhibited neutrophil and platelet accumulation, and reduced cerebral infarct volumes. Additional benefit was conferred by sialyl Lewis x glycosylation of the unmodified parent sCR1 molecule.
Assuntos
Transtornos Cerebrovasculares/tratamento farmacológico , Ataque Isquêmico Transitório/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Oligossacarídeos/uso terapêutico , Receptores de Complemento/uso terapêutico , Animais , Plaquetas/fisiologia , Adesão Celular , Córtex Cerebral/irrigação sanguínea , Córtex Cerebral/imunologia , Córtex Cerebral/metabolismo , Infarto Cerebral/tratamento farmacológico , Circulação Cerebrovascular , Transtornos Cerebrovasculares/imunologia , Transtornos Cerebrovasculares/fisiopatologia , Ativação do Complemento , Complemento C1q/metabolismo , Glicosilação , Humanos , Ataque Isquêmico Transitório/imunologia , Ataque Isquêmico Transitório/fisiopatologia , Leucócitos/fisiologia , Camundongos , Neurônios/imunologia , Neurônios/metabolismo , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/efeitos adversos , Fármacos Neuroprotetores/metabolismo , Neutrófilos/fisiologia , Oligossacarídeos/administração & dosagem , Oligossacarídeos/efeitos adversos , Oligossacarídeos/metabolismo , Adesividade Plaquetária , Receptores de Complemento/administração & dosagem , Receptores de Complemento/metabolismo , Traumatismo por Reperfusão/tratamento farmacológico , Traumatismo por Reperfusão/imunologia , Traumatismo por Reperfusão/metabolismo , Selectinas/metabolismo , Antígeno Sialil Lewis X , Fatores de TempoRESUMO
Soluble human complement receptor type 1 (sCR1, TP10) has been expressed in Chinese hamster ovary (CHO) DUKX-B11 cells and shown to inhibit the classical and alternative complement pathways in vitro and in vivo. A truncated version of sCR1 lacking the long homologous repeat-A domain (LHR-A) containing the C4b binding site has similarly been expressed and designated sCR1[desLHR-A]. sCR1[desLHR-A] was shown to be a selective inhibitor of the alternative complement pathway in vitro and to function in vivo. In this study, sCR1 and sCR1[desLHR-A] were expressed in CHO LEC11 cells with an active alpha(1,3)-fucosyltransferase, which makes possible the biosynthesis of the sialyl-Lewisx (sLex) tetrasaccharide (NeuNAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAc) during post-translational glycosylation. The resulting glycoproteins, designated sCR1sLex and sCR1[desLHR-A]sLex, respectively, retained the complement regulatory activities of their DUKX B11 counterparts, which lack alpha(1-3)-fucose. Carbohydrate analysis of purified sCR1sLex and sCR1[desLHR-A]sLex indicated an average incorporation of 10 and 8 mol of sLex/mol of glycoprotein, respectively. sLex is a carbohydrate ligand for the selectin adhesion molecules. sCR1sLex was shown to specifically bind CHO cells expressing cell surface E-selectin. sCR1[desLHR-A]sLex inhibited the binding of the monocytic cell line U937 to human aortic endothelial cells, which had been activated with tumor necrosis factor-alpha to up-regulate the expression of E-selectin. sCR1sLex inhibited the binding of U937 cells to surface-adsorbed P-selectin-IgG. sCR1sLex and sCR1[desLHR-A]sLex have thus demonstrated both complement regulatory activity and the capacity to bind selectins and to inhibit selectin-mediated cell adhesion in vitro.
Assuntos
Ativação do Complemento/efeitos dos fármacos , Glicoproteínas/farmacologia , Selectinas/metabolismo , Animais , Western Blotting , Células CHO , Adesão Celular , Cricetinae , Eletroforese/métodos , Citometria de Fluxo , Glicoproteínas/química , Humanos , Espectrometria de Massas , Monossacarídeos/análise , Oligossacarídeos/análise , Ligação Proteica , Ensaio Radioligante , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacologia , Células U937 , Regulação para CimaRESUMO
A 5-year-old Quarter Horse was examined after it developed signs of abdominal discomfort as a result of a training accident. Oral mucous membranes were pale, and capillary refill time was > 3 seconds. Hematologically, the PCV was low, and abdominocentesis yielded a serosanguineous fluid. Abdominal ultrasonography was performed and revealed a large hypoechoic mass associated with the cranial margin of the spleen. Because differentiation between subcapsular hematoma and extracapsular hematoma could not be made with certainty, further evaluation of the spleen was indicated. Abdominal laparoscopy was performed, with the horse standing, to evaluate the extent, severity, and nature of the splenic hematoma. Laparoscopic examination revealed a 7.5-cm-diameter splenic hematoma contained within the splenic capsule, confirming the diagnosis of subcapsular splenic hematoma. Abdominal laparoscopy provided excellent observation of the spleen and allowed for thorough evaluation and determination of the extent of the lesion. This information aided the clinician in reaching a definitive diagnosis and choosing between splenectomy and medical treatment.
Assuntos
Hematoma/veterinária , Doenças dos Cavalos/diagnóstico , Laparoscopia/veterinária , Esplenopatias/veterinária , Animais , Diagnóstico Diferencial , Feminino , Hematoma/diagnóstico , Cavalos , Baço/lesões , Esplenopatias/diagnósticoRESUMO
An 11-month-old female Vietnamese pot-bellied pig was examined for severe dehydration and neurologic signs including disorientation, ataxia, blindness, and involuntary twitching of the muscles of the neck and head. Biochemical analyses of serum revealed hypernatremia, hyperchloremia, hyperkalemia, azotemia, hyperphosphatemia, hyperalbuminemia, and high activities of aspartate transaminase and creatine kinase. A diagnosis of salt toxicosis/water deprivation was made. Medical management consisted of intravenous administration of a high-sodium crystalloid solution, anti-inflammatory drugs, and other supportive care. Sodium concentration of fluids administered intravenously was adjusted to be slightly less than the pig's serum sodium concentration so that the serum sodium concentration was reduced gradually over 48 hours. Resolution of clinical signs was rapid and the pig was discharged after 8 days of hospitalization. Fourteen days after the initial examination, the pig appeared healthy except for visual deficits. Historically, prognosis with conventional treatment of salt toxicosis/water deprivation is poor; however, this alternative approach to treating this condition appears promising.
Assuntos
Hipernatremia/veterinária , Soluções para Reidratação , Bicarbonato de Sódio/uso terapêutico , Cloreto de Sódio/uso terapêutico , Doenças dos Suínos/tratamento farmacológico , Porco Miniatura , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Edema Encefálico/tratamento farmacológico , Edema Encefálico/etiologia , Edema Encefálico/veterinária , Desidratação/complicações , Desidratação/terapia , Desidratação/veterinária , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Dimetil Sulfóxido/administração & dosagem , Dimetil Sulfóxido/uso terapêutico , Combinação de Medicamentos , Feminino , Hidratação/veterinária , Hipernatremia/complicações , Hipernatremia/tratamento farmacológico , Infusões Intravenosas/veterinária , Soluções para Reidratação/química , Sódio/sangue , Bicarbonato de Sódio/administração & dosagem , Cloreto de Sódio/administração & dosagem , Suínos , Doenças dos Suínos/etiologia , Privação de ÁguaRESUMO
Ocular contents from a horse with a 4-week history of severe unilateral uveitis were submitted for histopathologic examination. A severe unilateral granulomatous chorioretinitis with intralesional Halicephalobus deletrix was diagnosed. The horse developed progressive neurologic signs several days following the surgery to remove ocular contents and implant a prosthesis and was subsequently euthanatized. A severe multifocal granulomatous encephalitis with intralesional H. deletrix, localized primarily to the optic chiasm, thalamus, and brain stem, was diagnosed from tissues acquired at necropsy. The other eye was not affected. This is the first report of ocular parasitism by H. deletrix and suggests possible systemic dissemination from a primary site in the eye.
Assuntos
Coriorretinite/veterinária , Infecções Oculares Parasitárias/veterinária , Doenças dos Cavalos/patologia , Infecções por Rhabditida/veterinária , Uveíte/veterinária , Animais , Tronco Encefálico/patologia , Coriorretinite/parasitologia , Coriorretinite/patologia , Encefalomielite Equina/patologia , Infecções Oculares Parasitárias/patologia , Doenças dos Cavalos/parasitologia , Cavalos , Masculino , Infecções por Rhabditida/patologia , Tálamo/patologia , Uveíte/parasitologia , Uveíte/patologiaRESUMO
Two different fluid solutions were infused through percutaneous cecal catheters in 6 healthy ponies to determine the effects on body weight; CBC; packed cell volume (PCV); total plasma protein concentration; plasma fibrinogen concentration; abdominal fluid analysis; concentrations of blood urea nitrogen (BUN), serum creatinine, Ca, total CO2 (TCO2), Na, Cl, K, and P; and fractional clearance (FC) of Na, Cl, K, and P. During intracecal administration of solution 1, FCNa and FCCl were significantly increased, whereas FCK and BUN were significantly decreased. During administration of solution 2, FCNa and serum P were significantly increased, while PCV was significantly decreased. All ponies developed peritonitis during the study. Complications included catheter-related problems, diarrhea, laminitis, and hypocalcemia. We concluded that hydration and electrolyte balance could be maintained by administration of crystalloid solutions intracecally, but that complications were associated with the procedure.
Assuntos
Cateteres de Demora/veterinária , Hidratação/veterinária , Cavalos , Animais , Cateteres de Demora/efeitos adversos , Ceco , Feminino , Hidratação/métodos , Masculino , Projetos Piloto , Resultado do TratamentoRESUMO
Right dorsal colitis in horses has been associated with administration of phenylbutazone. Although reports of right dorsal colitis in this species have described surgical treatment associated with a poor prognosis, we have had success treating this condition medically. This report describes 5 horses with right dorsal colitis confirmed during celiotomy that were initially managed medically. All horses had a history of intermittent abdominal pain; weight loss was noted in only 1 horse. The doses (2.0 to 4.6 mg/kg PO bid) and duration (5 to 30 days) of administration of phenylbutazone were not unusually high relative to those recommended (4.4 mg/kg PO bid). Hypoproteinemia and hypoalbuminemia were observed in all horses at the time of admission; packed cell volume was low in 4 horses, and hypocalcemia was also observed in 4 horses. Three of 5 horses (60%) appeared to respond to dietary management and discontinuation of administration of nonsteroidal anti-inflammatory drugs. Dietary management consisted of feeding pelleted feed, and restricting or eliminating roughage for a period of at least 3 months. Two horses developed strictures of the right dorsal colon. One horse that developed a colonic stricture, possibly because its owners did not comply with recommendations for management, was subsequently treated surgically. The remaining horse that developed a stricture of the right dorsal colon was euthanized. These data indicate that some horses with right dorsal colitis can be successfully managed with medical treatment.